i-LipoP® for mRNA
Nucleic Acid Therapeutics/Vaccines
Pre-clinicalActive
Key Facts
About Adjuvatis
Adjuvatis is a private, pre-revenue biotech platform company specializing in innovative, safe-by-design nanoparticle delivery systems. Its proprietary i-Particles® (biodegradable polymer particles) and i-LipoP® (lipid-bilayer coated particles for nucleic acid delivery) technologies aim to overcome formulation challenges in vaccines, drug delivery, and diagnostics. The company leverages a collaborative model, offering analytical services and custom formulations to partners while positioning itself in the growing markets for advanced vaccine adjuvants and mRNA delivery solutions.
View full company profile